COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
Currently no drug is approved for the prophylaxis and management of COVID 19. Lots of activities on vaccine and trials with drugs are underway. Some evidence have shown positive results using older established drug in the management of severe cases. We are also of same view and opinion to adopt some...
Main Authors: | Pugazhenthan Thangaraju, Meenalotchini P Gurunthalingam, Shobanbabu Varthya, Sajitha Venkatesan, Eswaran Thangaraju |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=5;spage=2172;epage=2175;aulast=Thangaraju |
Similar Items
-
Chloroquine induced utricaria—A detailed history helps
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01) -
COVID 19'da N95 maskesinin yeniden kullanımı pandemik stratejiler ve ihtiyat
by: Pugazhenthan Thangaraju, et al.
Published: (2020-09-01) -
Ebola drug trial: a ray of hope
by: Shobanbabu Varthya, et al.
Published: (2019-12-01) -
Rationale use of Thalidomide in erythema nodosum leprosum - A non-systematic critical analysis of published case reports
by: Pugazhenthan Thangaraju, et al.
Published: (2020-09-01) -
Cephalosporin's induced hepatic enzyme derangement - An educational report
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)